Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-04 | Dr. Joanne M. DonovanChief Medical Officer | -5,23k | 163,66k | Automatic Disposition | 31,29 | 4,37k | -54,50% |
| 2026-05-05 | Dr. Joanne M. DonovanChief Medical Officer | -50,00k | 1,57M | Derivative Exercise and Sale | 7,08 - 38,57 | 4,37k | - |
| 2026-04-01 | Dr. Joanne M. DonovanChief Medical Officer | -28,66k | 723,17k | Derivative Exercise and Sale | 7,08 - 32,31 | 9,60k | - |
| 2026-03-31 | Dr. Joanne M. DonovanChief Medical Officer | -21,34k | 534,24k | Derivative Exercise and Sale | 7,08 - 32,12 | 9,60k | - |
| 2026-03-27 | Dr. Joanne M. DonovanChief Medical Officer | -16,36k | 506,73k | Verkauf | 30,98 | 9,60k | -63,02% |
| 2026-01-21 | Dr. Badreddin EdrisCo-Founder & Independent Director | -115,47k | 3,23M | Derivative Exercise and Sale | 0,39 - 29,44 | 19,82k | - |
| 2025-11-12 | Dr. Alan J. RussellCo-Founder, Chief Scientific Officer & Director | -100,00k | 2,09M | Derivative Exercise and Sale | 0,18 - 21,12 | 23,40k | - |
| 2025-11-11 | Dr. Jonathan C. FoxIndependent Director | 10,70k | 199,40k | Kauf | 18,64 | 23,70k | 82,30% |
| 2025-08-26 | Dr. Alan J. RussellCo-Founder, Chief Scientific Officer & Director | -100,00k | 1,44M | Derivative Exercise and Sale | 0,18 - 14,60 | 23,40k | - |
| 2025-08-12 | Mr. John R. MooreGeneral Counsel | 3,68k | 0,00 | Derivative Exercise and Retained Stock | - | 10,21k | 56,39% |
| 2025-08-12 | Mr. John R. MooreGeneral Counsel | -2,10k | 28,10k | Derivative Exercise and Sale | 13,39 | 10,21k | - |
| 2025-08-12 | Dr. Behrad DerakhshanCOO | 3,29k | 0,00 | Derivative Exercise and Retained Stock | - | 23,65k | 16,16% |
| 2025-08-12 | Dr. Behrad DerakhshanCOO | -2,49k | 33,36k | Derivative Exercise and Sale | 13,39 | 23,65k | - |
| 2025-08-12 | Dr. Alan J. RussellCo-Founder, Chief Scientific Officer & Director | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 23,40k | 19,84% |
| 2025-08-12 | Dr. Alan J. RussellCo-Founder, Chief Scientific Officer & Director | -1,91k | 25,54k | Derivative Exercise and Sale | 13,39 | 23,40k | - |
| 2025-08-12 | Mr. R. Michael CarruthersInsider | 4,35k | 0,00 | Derivative Exercise and Retained Stock | - | 86,16k | 5,32% |
| 2025-08-12 | Mr. R. Michael CarruthersInsider | -1,43k | 19,12k | Derivative Exercise and Sale | 13,39 | 86,16k | - |
| 2025-08-12 | Dr. Joanne M. DonovanChief Medical Officer | 2,92k | 0,00 | Derivative Exercise and Retained Stock | - | 25,36k | 13,01% |
| 2025-08-12 | Dr. Joanne M. DonovanChief Medical Officer | -2,86k | 38,33k | Derivative Exercise and Sale | 13,39 | 25,36k | - |
| 2025-08-12 | Dr. Kevin KochPresident, CEO & Director | 10,00k | 0,00 | Derivative Exercise and Retained Stock | - | 369,40k | 2,78% |
| 2025-08-12 | Dr. Kevin KochPresident, CEO & Director | -7,97k | 106,76k | Derivative Exercise and Sale | 13,39 | 369,40k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
